[go: up one dir, main page]

WO2016043382A1 - Dispositif de traitement de la rhinite et procédé de commande d'un dispositif de traitement de la rhinite - Google Patents

Dispositif de traitement de la rhinite et procédé de commande d'un dispositif de traitement de la rhinite Download PDF

Info

Publication number
WO2016043382A1
WO2016043382A1 PCT/KR2014/011723 KR2014011723W WO2016043382A1 WO 2016043382 A1 WO2016043382 A1 WO 2016043382A1 KR 2014011723 W KR2014011723 W KR 2014011723W WO 2016043382 A1 WO2016043382 A1 WO 2016043382A1
Authority
WO
WIPO (PCT)
Prior art keywords
magnetic field
light source
light
rhinitis treatment
treatment device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2014/011723
Other languages
English (en)
Korean (ko)
Inventor
이용흠
이나라
류근웅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Yonsei University
Original Assignee
Industry Academic Cooperation Foundation of Yonsei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54346732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2016043382(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Industry Academic Cooperation Foundation of Yonsei University filed Critical Industry Academic Cooperation Foundation of Yonsei University
Publication of WO2016043382A1 publication Critical patent/WO2016043382A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head

Definitions

  • the present application relates to a rhinitis treatment device and a method of driving the rhinitis treatment device for generating light and magnetic field.
  • Rhinitis refers to an inflammatory disease of the nasal mucosa accompanied by one or more symptoms of runny nose, sneezing, itching and stuffy nose.
  • Acute rhinitis is an infectious rhinitis, commonly referred to as a cold, and chronic rhinitis caused by bacteria can occur when rhinitis occurs repeatedly due to incomplete treatment for acute rhinitis.
  • the rhinitis treatment device used for the treatment of rhinitis treats inflammation by irradiating light in a specific wavelength range, such as an infrared ray therapy device or a laser therapy device, in the nasal cavity.
  • the light irradiator used is a device using a method of irradiating light to the affected area of the nasal cavity, and uses a single light source such as red light or blue light.
  • a light irradiator capable of taking in various wavelength bands is required.
  • the present application is to solve the above-mentioned problems of the prior art, by irradiating the red light and / or blue light and the time-varying magnetic field at the same time into the nasal cavity, rhinitis treatment device that can enhance the rhinitis treatment effect, a method of driving the rhinitis treatment device, and light and It is intended to provide a magnetic field generating device.
  • the red light of the LED is used to activate the function of intranasal cells to restore trauma, alleviate damaged optical nerve deterioration, repair ischemic wounds, a rhinitis treatment device with a strong anti-inflammatory effect, a method of driving a rhinitis treatment device, and a light and magnetic field It is intended to provide a generator.
  • the present invention aims to provide a rhinitis treatment device, a method of driving a rhinitis treatment device, and an optical and magnetic field generating device which sterilizes phospholipids and proteins constituting intranasal cell membranes using blue light of LEDs to prevent proliferation of bacteria.
  • Pulsed Electromagnetic Fields increase blood flow, which promotes blood circulation, stimulates nasal affected cells to promote recovery, rhinitis treatment devices, how to drive rhinitis treatment devices, and light and magnetic fields It is intended to provide a generator.
  • the rhinitis treatment apparatus is a first light source for irradiating the nasal cavity of the user with a first light having a first wavelength, the second light having a second wavelength
  • a second light source for irradiating the nasal cavity a magnetic field generator positioned outside of the nasal cavity and generating a magnetic field toward the nasal cavity, and controlling the operation of at least one or more of the first light source and the second light source and the operation of the magnetic field generator. It may include a control unit.
  • the controller may operate the magnetic field generator together while at least one of the first light source and the second light source is operating.
  • the rhinitis treatment apparatus further includes a user input unit configured to receive a user input for selecting the magnetic field strength of the magnetic field generator, and the controller may further determine the magnetic field strength of the magnetic field generator based on the user input. I can regulate it.
  • the user input unit further receives a user input for selecting the operating time of the rhinitis treatment device, the control unit based on the user input for the operating time the first light source and the second
  • the operation of at least one of the light sources and the operation of the magnetic field generator may be controlled.
  • the rhinitis treatment device may further include a power supply unit for supplying power to the rhinitis treatment device and a button for controlling on / off of the rhinitis treatment device.
  • the controller may alternately operate the first light source and the second light source at predetermined intervals.
  • control unit is configured such that the magnetic field generator generates a first magnetic field when the first light source is operated, and the magnetic field generator generates a second magnetic field when the second light source is operated.
  • the magnetic field generator is operated, and the first magnetic field and the second magnetic field may have any one of different generation times, types or sizes.
  • the type may include a monophasic type and a biphasic type.
  • the first wavelength may have a wavelength band of 415 nm
  • the second wavelength may have a wavelength band of 650 nm.
  • the first light may be blue light
  • the second light may be red light
  • the first light source and the second light source may be a light emitting diode (LED).
  • LED light emitting diode
  • the magnetic field may be pulsed electromagnetic fields (PEMFs).
  • PEMFs pulsed electromagnetic fields
  • the magnetic field generator may include two coil guides facing each other, a magnetic body installed between the two coil guides, and a coil wound around the magnetic body.
  • the diameter of the magnetic body may be selected in the range of 2mm to 5mm.
  • the diameter of the coil guide may be selected within the range of 10mm to 25mm according to the size of the diameter of the magnetic body.
  • the rhinitis treatment device is connected to the first light source, the second light source, the magnetic field generator, the housing for accommodating the control unit and the housing, and fixes the housing to the user. May include more government.
  • the driving method of the rhinitis treatment apparatus has a first light source for irradiating the nasal cavity of the user with a first light having a first wavelength, the second wavelength Operating at least one of a second light source for irradiating a second light to the nasal cavity and operating a magnetic field generator for generating a magnetic field toward the nasal cavity while at least one of the first light source and the second light source is operating; It may include a step.
  • a recording medium is a first light source for irradiating the nasal cavity of the user with a first light having a first wavelength, the second light having a second wavelength
  • a first light source for irradiating the nasal cavity of the user with a first light having a first wavelength
  • the second light having a second wavelength
  • a program for executing the method of driving the rhinitis treatment device on a computer can be recorded.
  • an apparatus for generating light and a magnetic field is to irradiate an object with a first light having a first wavelength based on a control signal received from a control device
  • It may include a magnetic field generator for generating a magnetic field toward the object.
  • any one of the above-mentioned means for solving the problems of the present invention by irradiating at least one of the red light and blue light and the magnetic field into the nasal cavity at the same time, it is possible to increase the rhinitis treatment effect.
  • any one of the above-described means for solving the problems of the present invention by using the red light of the LED to activate the function of intranasal cells to restore trauma, alleviate damaged optical nerve deterioration, recovery of ischemic wounds, rhinitis with strong anti-inflammatory effect It is possible to provide a treatment device, a method of driving a rhinitis treatment device, and an optical and magnetic field generating device.
  • any one of the above-described means for solving the problem of the present invention using a blue light of the LED to oxidize the phospholipids and proteins constituting the intranasal cell membrane to sterilize so that the life activities of bacteria, sterilization treatment device, rhinitis treatment device driving And a light and magnetic field generating device.
  • any one of the above-described means for solving the problem of the present invention by increasing the blood flow by using a weak magnetic field (PEMFs, Pulsed Electromagnetic Fields), promotes blood circulation, stimulates the affected cells in the nasal cavity to promote recovery
  • PEMFs Pulsed Electromagnetic Fields
  • FIG. 1 is a block diagram of a rhinitis treatment apparatus according to an embodiment of the present invention.
  • FIG. 2a to 2b is a view showing a rhinitis treatment apparatus according to an embodiment of the present invention.
  • FIG 3 is a view showing a light source unit according to an embodiment of the present invention.
  • FIG. 4 is a diagram illustrating a magnetic field generator according to an embodiment of the present invention.
  • FIG. 5 is a flowchart illustrating a method of driving a rhinitis treatment apparatus according to an embodiment of the present invention.
  • the rhinitis treatment apparatus 100 may include a first light source 110, a second light source 120, a magnetic field generator 130, a controller 140, and a user input unit ( 150).
  • the rhinitis treatment device 100 may be configured differently from FIG. 1.
  • the rhinitis treatment apparatus 100 may further include a plurality of lights and a plurality of magnetic field generators.
  • the first light source 110 may irradiate the nasal cavity of the user with the first light having the first wavelength.
  • the first light source may be set to blue light, and the first wavelength may be set to a wavelength of 415 nm.
  • the first wavelength of the first light may be selected within the range of 200 nm to 400 nm. Blue light has a bactericidal effect that oxidizes the phospholipids and proteins that make up the nasal cell membranes and prevents bacteria from prolonging their life.
  • the second light source 120 may irradiate the nasal cavity of the user with the second light having the second wavelength.
  • the second light source may be set to red light
  • the second wavelength may be set to a wavelength of 650 nm.
  • the second wavelength of the second light may be selected within the range of 630 nm to 1000 nm, preferably 630 nm to 670 nm. Red light activates the function of intranasal cells and has the effect of restoring trauma, relieving damaged optical nerve deterioration, ischemic wound recovery and strong anti-inflammatory effects.
  • the first light source 110 and the second light source 120 may alternately irradiate the first light and the second light according to a preset period. For example, after the first light source 110 irradiates the nasal cavity of the user with the first light for 30 seconds, when the irradiation of the first light is completed, the second light source 120 transmits the second light to the nasal cavity of the user for 30 seconds. Can be investigated.
  • the first light source 110 and the second light source 120 may include a light emitting diode (LED).
  • LEDs are more durable and smaller than lasers.
  • medical LEDs do not require high voltage.
  • the medical LED is less heat generation can be used for brachytherapy using the medical LED.
  • the LED can emit light in a wide wavelength range, and the narrow width of the wavelength has the advantage that it is easy to select the wavelength required for treatment.
  • the magnetic field generator 130 may generate a magnetic field toward the nasal cavity of the user.
  • the magnetic field generator 130 may be located outside the user nasal cavity. Sites where inflammation occurs in the nasal cavity are surrounded by bones, making physical treatment difficult. However, the magnetic field generator 130 may generate a magnetic field having a property of penetrating the medium toward the nasal cavity. Thus, intranasal inflammation can be effectively treated.
  • the magnetic field generated by the magnetic field generator 130 may be pulsed electromagnetic fields (PEMFs).
  • PEMFs pulsed electromagnetic fields
  • the magnetic field boosts the blood flow in the human body and facilitates the metabolism that combines oxygen and nutrients in the blood and transports them to each tissue and organ.
  • the magnetic field can promote blood circulation to quickly remove the waste in the body to prevent the disease.
  • the magnetic field promotes the ionic effect to normalize blood circulation, increase the oxygen efficiency to convert the characteristics of body fluids into healthy alkaline body fluids.
  • the magnetic field generator 130 may generate a magnetic field while at least one of the first light source 110 and the second light source 120 is operating. For example, the magnetic field generator 130 may generate a first magnetic field when the first light source 110 operates. In addition, the magnetic field generator 130 may generate a second magnetic field when the second light source 120 operates.
  • the first magnetic field and the second magnetic field may have any one of different generation times, types, or sizes.
  • the types of the first magnetic field and the second magnetic field may include a monophasic type and a biphasic type.
  • the controller 140 may control at least one operation of the first light source 110 and the second light source 120 and the operation of the magnetic field generator 130. For example, the controller 140 generates a control signal for controlling the operation of at least one or more of the first light source 110 and the second light source 120 and the operation of the magnetic field generator 130, and generates a first light source.
  • the control signal may be transmitted to the 110, the second light source 120, and the magnetic field generator 130.
  • the controller 140 may generate a control signal in consideration of a correlation between at least two of the first light source 110, the second light source 120, and the magnetic field generator 130. For example, the controller 140 may generate a control signal for operating the magnetic field generator 130 together while at least one of the first light source 110 and the second light source 120 is operating. . For another example, the controller 140 may generate a control signal for alternately operating the first light source 110 and the second light source 120 according to a specific period. In another example, the controller 140 may generate a control signal such that the magnetic field generator 130 generates a first magnetic field corresponding to the first light source 110 when the first light source 110 operates. Can be.
  • the controller 140 may generate a control signal such that when the second light source 120 operates, the magnetic field generator 130 generates a second magnetic field corresponding to the second light source 120.
  • the first magnetic field and the second magnetic field may have any one of different generation times, types, or sizes, and the types may include a monophasic type and a biphasic type.
  • the controller 140 may adjust the magnetic field strength of the magnetic field generator 130 based on a user input for selecting the magnetic field strength of the magnetic field generator 130 received from the user input unit 150 to be described later. For example, the strength of the magnetic field can be adjusted within the range of 100-300 Gauss.
  • the controller 140 may generate an electrical signal or a control signal for controlling the operation of the magnetic field generator 130 in response to the user input received through the user input unit 150.
  • the controller 140 may include at least one of the first light source 110 and the second light source 120 based on a user input for selecting an operation time of the rhinitis treatment apparatus 100 received from the user input unit 150 to be described later.
  • the above operation and the operation of the magnetic field generator 130 can be controlled.
  • the controller 140 may generate an electrical signal or a control signal for controlling the first light source 110, the second light source 120, and the magnetic field generator 130 in response to the user input received through the user input unit 150.
  • the rhinitis treatment apparatus 100 of the present application includes a light source operating unit (not shown) for operating the first light source 110 and the second light source 120 and a magnetic field generator for operating the magnetic field generator 130. It may further include an operation unit (not shown).
  • the light source operating unit may operate the first light source 110 and the second light source 120 based on a control signal received from the controller 140.
  • the magnetic field generator operation unit may operate the magnetic field generator 130 based on a control signal received from the controller 140.
  • the user input unit 150 may receive a user input for selecting the magnetic field strength of the magnetic field generator 130. In addition, the user input unit 150 may receive a user input for selecting an operating time of the rhinitis treatment device 100.
  • the user input unit 150 may include, but is not necessarily limited to, a switch, a button, a touch panel display, a motion recognition device, and the like, in which the user selects the strength and operation time of the magnetic field.
  • the user input unit 150 may be connected to the control unit 140 by wire through a cable to transmit a user input to the control unit 140.
  • the user input unit 150 may wirelessly transmit the user input to the controller 140 through a wireless communication device (not shown) installed inside the user input unit 150.
  • the rhinitis treatment apparatus 100 may further include a vibration generator (not shown).
  • the vibration generator may generate a vibration by receiving a control signal from the controller 140.
  • the vibration generator may generate vibration when the power of the rhinitis treatment apparatus 100 is turned on or paused.
  • the vibration generator may generate a vibration every 30 seconds to let the user know that the rhinitis treatment device 100 is operating smoothly.
  • the vibration generator may generate a first vibration when the first light source 110 operates, and may generate a second vibration when the second light source 120 operates.
  • the vibration generator may generate a third vibration when the magnetic field generator 130 operates. In this case, the first to third vibration may have a different vibration time or vibration form.
  • the rhinitis treatment apparatus 100 generating light and a magnetic field according to an exemplary embodiment of the present disclosure alternately irradiates the first and second lights of different wavelength bands at regular intervals to the user's nasal cavity, and the first light. While at least one of the second light and the second light is irradiated to the user's nasal cavity, the time-varying magnetic field can be generated and irradiated into the user's nasal cavity. Therefore, it is possible to maximize the effect of rhinitis treatment by stimulating the intranasal mucosa.
  • FIG. 2a to 2b is a view showing a rhinitis treatment apparatus according to an embodiment of the present invention.
  • Figure 2a is a view showing the front portion of the rhinitis treatment device.
  • Figure 2b is a view showing the back of the rhinitis treatment device.
  • the rhinitis treatment apparatus 200 may include a housing 202, a fixing portion 204, and an input portion 214.
  • the housing 202 may accommodate a light source unit 206, a control unit 208, a power supply unit 210, a magnetic field generator 250, and a nose support 260 including a first light source and a second light source. Also, although not shown in FIGS. 2A and 2B, the housing 202 may further include a constant current circuit for controlling the LED power of the light source unit 206 therein.
  • control unit 208 included in the housing 202, the magnetic field generator 250, the first light source and the second light source included in the light source unit 206 may include the control unit 140 included in the rhinitis treatment apparatus 100 of FIG. 1. ), The magnetic field generator 130, the first light source 110 and the second light source 120, respectively, so that the duplicated content will be omitted.
  • the fixing part 204 may be connected to the housing 202 and may be fixed to the user 220 so that the user 220 does not have to grip the rhinitis treatment device 200 by hand.
  • the fixing part 204 may be in the form of glasses legs, a ring, a belt, but is not necessarily limited thereto, and various forms may exist.
  • the light source unit 206 may include a plurality of light generating units.
  • the light source unit 206 may include a plurality of light generation units that may be inserted into the left nostril and the right nostril of the user 220, respectively.
  • the light source unit 206 may include, for example, a 2-tone LED that may emit red light and blue light simultaneously or alternately.
  • the power supply unit 210 may receive power from the outside to supply power to the rhinitis treatment apparatus 200. Although not shown in FIGS. 2A and 2B, a separate power cable connected to the power supply unit 210 may be connected. As another example, the power supply unit 210 may include a rechargeable battery, a battery, a mercury battery, or the like without a power cable, and may supply power to the rhinitis treatment apparatus 200 without receiving power from the outside.
  • One end of the cable 212 may be connected to the housing 202, and the other end of the cable 212 may be connected to a user input unit 214 that receives a user input.
  • a user input for selecting the magnetic field strength of the magnetic field generator 250 or a user input for selecting an operation time of the rhinitis treatment apparatus 200 may be transmitted from the user input unit 214 to the controller 208 through the cable 212.
  • One example of the cable 212 may be one of a variety of media such as, for example, a metal medium such as copper, gold, silver or an optical fiber.
  • the user input unit 214 may set whether or not the rhinitis treatment apparatus 200 operates.
  • the controller 208 generates an electrical signal or a control signal in response to one or more inputs received through the user input unit 214.
  • the user input unit 214 may control an on / off operation of the power display unit 216 and the rhinitis treatment apparatus 200 indicating an operating state of the rhinitis treatment apparatus 200.
  • Which may include a power button 218.
  • An example of such a user input unit 214 includes, but is not limited to, a hardware button, a touch panel display, and a motion recognition device.
  • the rhinitis treatment apparatus 200 may be operated.
  • the operation of the rhinitis treatment apparatus 200 may be stopped.
  • the power display unit 216 may indicate the state of the rhinitis treatment apparatus 200 based on the setting of the operation of the user input unit 214. For example, when the power input unit 216 sets the operation of the rhinitis treatment apparatus 200 to ON in the user input unit 214, the power display unit 216 generates light of red, blue, or fluorescent colors, thereby causing the rhinitis treatment apparatus 200. ) Can indicate that it is currently running. For another example, the power display unit 216 does not generate light when the user input unit 214 sets the operation of the rhinitis treatment apparatus 200 to OFF, thereby preventing the rhinitis treatment apparatus 200 from present. It may indicate that it is not working.
  • the user input unit 214 may further include a switch for the user to select the strength of the magnetic field and the operating time of the rhinitis treatment apparatus 200.
  • the light source unit 300 may include a first light source 310, a second light source 320, and a light source cover 330.
  • the light source cover 330 covers the first light source 310 and the second light source 320 to protect the first light source 310 and the second light source 320 from external impact.
  • the light source cover 330 may be made of a transparent plastic, a transparent PVC, a transparent synthetic resin, or the like, and may be directly inserted into a user's nasal cavity.
  • the first light source 310 may radiate the first light having the first wavelength.
  • the first light may be set to a wavelength of 415 nm as blue light.
  • Blue light has a bactericidal effect that oxidizes the phospholipids and proteins that make up the nasal cell membranes and prevents bacteria from prolonging their life.
  • the second light source 320 may irradiate the second light having the second wavelength.
  • the second light may be set to a wavelength of 650 nm as red light. Red light activates the function of intranasal cells and has the effect of restoring trauma, relieving damaged optical nerve deterioration, ischemic wound recovery and strong anti-inflammatory effects.
  • the light source unit 300 may include a plurality of light sources 310 and 320, and may irradiate a plurality of lights having different wavelength bands simultaneously or alternately according to a predetermined period.
  • the magnetic field generator 400 according to an embodiment of the present invention includes two coil guides 410 facing each other, a magnetic body 420 installed between the two coil guides 410, and The coil 430 wound on the magnetic material 420 may be included.
  • the diameter of the magnetic body 420 may be selected within the range of 2mm to 5mm.
  • the diameter of the coil guide 410 may be selected within the range of 10mm to 25mm according to the size of the diameter of the magnetic body 420.
  • the diameter of the coil guide 410 may be selected in proportion to the size of the diameter of the magnetic body 420.
  • the distance between the two coil guide 410 according to an embodiment of the present application that is, the length of the magnetic body 420 is kept constant regardless of the size of the diameter of the coil guide 410 or the magnetic body 420 Can be.
  • the two coil guides 410 may be made of a plastic material.
  • the magnetic body 420 may be made of a SM45C material.
  • the coil guide 410 is illustrated in a circular shape, and the magnetic body 420 is illustrated in a cylindrical shape, but shapes of the coil guide 410 and the magnetic body 420 are not limited thereto.
  • a time-varying magnetic field is generated by the magnetic body 420 and the coil 430 wound around the magnetic body 420.
  • the generated magnetic field may be pulsed electromagnetic fields stimulation (PEMFs).
  • PEMFs pulsed electromagnetic fields stimulation
  • the biocurrent is generated by the time-varying magnetic field, and the affected cells are stimulated by the biocurrent to promote rhinitis treatment and recovery.
  • the intensity of the magnetic field generated from the magnetic field generator 400 may be adjusted within a range of 100 to 300 Gauss depending on the size of the magnetic body 420 of the magnetic field generator 400 and the number of turns of the coil 430.
  • FIG. 5 is a flowchart illustrating a method of driving a rhinitis treatment apparatus according to an embodiment of the present invention.
  • the driving method of the rhinitis treatment apparatus shown in FIG. 5 is performed by a rhinitis treatment apparatus including the first light source, the second light source, and the magnetic field generator described above with reference to FIGS. 1 to 4. Therefore, even if omitted below, the contents described for the rhinitis treatment apparatus through FIGS. 1 to 4 also apply to FIG. 5.
  • step S510 the control device (or control unit) generates a control signal.
  • the control device operates at least one of the first light source and the second light source based on the control signal.
  • the first light source may irradiate the nasal cavity of the user with the first light having the first wavelength
  • the second light source may irradiate the nasal cavity of the user with the second light having the second wavelength.
  • the control device operates the magnetic field generator to generate a magnetic field toward the nasal cavity while at least one of the first light source and the second light source is operating based on a control signal.
  • Computer readable media can be any available media that can be accessed by a computer and includes both volatile and nonvolatile media, removable and non-removable media.
  • Computer readable media may include both computer storage media and communication media.
  • Computer storage media includes both volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data.
  • Communication media typically includes computer readable instructions, data structures, program modules, or other data in a modulated data signal such as a carrier wave, or other transmission mechanism, and includes any information delivery media.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Magnetic Treatment Devices (AREA)

Abstract

L'invention concerne un dispositif de traitement de la rhinite qui peut comprendre : une première source de lumière pour exposer la cavité nasale d'un utilisateur à une première lumière ayant une première longueur d'onde ; une seconde source de lumière pour exposer la cavité nasale à une seconde lumière ayant une seconde longueur d'onde ; un générateur de champ magnétique positionné à l'extérieur de la cavité nasale, et générant un champ magnétique vers la cavité nasale ; et une unité de commande pour commander le fonctionnement de la première source de lumière et/ou de la seconde source de lumière et le fonctionnement du générateur de champ magnétique.
PCT/KR2014/011723 2014-09-16 2014-12-02 Dispositif de traitement de la rhinite et procédé de commande d'un dispositif de traitement de la rhinite Ceased WO2016043382A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0122486 2014-09-16
KR1020140122486A KR101558180B1 (ko) 2014-09-16 2014-09-16 비염 치료 장치 및 비염 치료 장치의 구동 방법

Publications (1)

Publication Number Publication Date
WO2016043382A1 true WO2016043382A1 (fr) 2016-03-24

Family

ID=54346732

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/011723 Ceased WO2016043382A1 (fr) 2014-09-16 2014-12-02 Dispositif de traitement de la rhinite et procédé de commande d'un dispositif de traitement de la rhinite

Country Status (2)

Country Link
KR (1) KR101558180B1 (fr)
WO (1) WO2016043382A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111135473A (zh) * 2020-01-16 2020-05-12 福鑫福电子科技(深圳)有限公司 光照保健装置
EP3705160A4 (fr) * 2017-11-01 2021-08-11 Double H Ltd. Dispositif de traitement de la rhinite pouvant être porté sur le visage et utilisant la luminothérapie
WO2022225112A1 (fr) * 2021-04-20 2022-10-27 주식회사 프록시헬스케어 Appareil de traitement de la rhinite
WO2022267076A1 (fr) * 2021-06-22 2022-12-29 中国科学院苏州生物医学工程技术研究所 Instrument de photothérapie contre la rhinite
US12357817B2 (en) 2021-04-06 2025-07-15 Aerin Medical Inc. Nasal neuromodulation devices and methods

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108778414B (zh) * 2016-01-06 2022-04-29 艾奇化妆品私人有限公司 用于治疗鼻部疾病的光疗系统
KR102453464B1 (ko) * 2019-12-27 2022-10-12 주식회사 노드 자기장 발생 장치 및 그의 구동 방법
CN114167624A (zh) * 2021-12-03 2022-03-11 固安翌光科技有限公司 一种眼镜
KR20240071446A (ko) 2022-11-14 2024-05-23 박원일 비접촉식 비염 예방 및 치료 장치

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110276107A1 (en) * 2005-11-10 2011-11-10 ElectroCore, LLC. Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders
KR20130084937A (ko) * 2012-01-18 2013-07-26 주식회사 네오닥터 휴대용 피부 치료장치
US20130204120A1 (en) * 2012-02-08 2013-08-08 Weinberg Medical Physics Llc Equipment and methodologies for magnetically-assisted delivery of therapeutic agents through barriers
KR101431201B1 (ko) * 2013-05-06 2014-08-21 주식회사 에이치엘앤피 비염 또는 중이염 치료를 위한 광선치료기

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110276107A1 (en) * 2005-11-10 2011-11-10 ElectroCore, LLC. Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders
KR20130084937A (ko) * 2012-01-18 2013-07-26 주식회사 네오닥터 휴대용 피부 치료장치
US20130204120A1 (en) * 2012-02-08 2013-08-08 Weinberg Medical Physics Llc Equipment and methodologies for magnetically-assisted delivery of therapeutic agents through barriers
KR101431201B1 (ko) * 2013-05-06 2014-08-21 주식회사 에이치엘앤피 비염 또는 중이염 치료를 위한 광선치료기

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3705160A4 (fr) * 2017-11-01 2021-08-11 Double H Ltd. Dispositif de traitement de la rhinite pouvant être porté sur le visage et utilisant la luminothérapie
CN111135473A (zh) * 2020-01-16 2020-05-12 福鑫福电子科技(深圳)有限公司 光照保健装置
US12357817B2 (en) 2021-04-06 2025-07-15 Aerin Medical Inc. Nasal neuromodulation devices and methods
WO2022225112A1 (fr) * 2021-04-20 2022-10-27 주식회사 프록시헬스케어 Appareil de traitement de la rhinite
WO2022267076A1 (fr) * 2021-06-22 2022-12-29 中国科学院苏州生物医学工程技术研究所 Instrument de photothérapie contre la rhinite

Also Published As

Publication number Publication date
KR101558180B1 (ko) 2015-10-08

Similar Documents

Publication Publication Date Title
WO2016043382A1 (fr) Dispositif de traitement de la rhinite et procédé de commande d'un dispositif de traitement de la rhinite
WO2016163776A1 (fr) Dispositif de traitement d'oreille interne et procédé de fonctionnement de dispositif de traitement d'oreille interne
WO2019098531A1 (fr) Système de masque led à fonction iontophorétique
US20070208397A1 (en) Device and method of phototherapy for jaundiced infants
KR101612330B1 (ko) 비염 치료 장치 및 비염 치료 장치의 구동 방법
WO2017150906A1 (fr) Dispositif de soin de la peau
WO2011115451A2 (fr) Appareil de photothérapie
WO2016060289A1 (fr) Système de luminothérapie à faible niveau, adhérant à la peau, fondé sur la technologie pams, utilisant un dispositif de communication mobile
US20100106228A1 (en) Device and method of phototherapy for jaundiced infants
WO2013147424A1 (fr) Appareil de stimulation d'énergie méridienne abdominale de type ceinture utilisant une diode électroluminescente
KR20160095574A (ko) 휴대용 비염 치료기
WO2022103097A1 (fr) Casque à émission de lumière comprenant une unité de génération de champ électromagnétique et sa méthode de fonctionnement
WO2013172859A1 (fr) Appareil pour le maintien d'un traitement de neuropathie périphérique
WO2021153893A1 (fr) Dispositif électroluminescent de traitement de la peau durant le sommeil
WO2017200261A1 (fr) Dispositif dentaire et procédé d'entraînement pour dispositif dentaire
WO2010011024A2 (fr) Appareil portable pour traitement photocutané
KR102146759B1 (ko) 다용도 휴대용 광치료기
WO2012153946A2 (fr) Machine opératoire chirurgicale laser compatible haute fréquence/basse fréquence
US20250144436A1 (en) Arthritis pain treatment device and driving method therefor
KR20100013650A (ko) 로프형 광 치료 장치
KR102386722B1 (ko) 헬멧형 두피관리기기 및 그 기기의 구동방법
KR101630847B1 (ko) 광역학치료용 광원 모듈
CN205379448U (zh) 一种侵入式光谱妇科疾病治疗装置
SK6800Y1 (sk) Zariadenie na vykonávanie stimulácie mozgu laserovým kruhovo alebo elipticky polarizovaným svetlom
KR20160120086A (ko) 화상 치료 장치 및 화상 치료 장치의 구동 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14901977

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 14901977

Country of ref document: EP

Kind code of ref document: A1